Practical and Efficient Strategy for Evaluating Oral Absolute Bioavailability with an Intravenous Microdose of a Stable Isotopically-Labeled Drug Using a Selected Reaction Monitoring Mass Spectrometry Assay
Citations Over TimeTop 10% of 2012 papers
Abstract
A strategy of using selected reaction monitoring (SRM) mass spectrometry for evaluating oral absolute bioavailability with concurrent intravenous (i.v.) microdosing a stable isotopically labeled (SIL) drug was developed and validated. First, the isotopic contribution to SRM (ICSRM) of the proposed SIL drug and SIL internal standard (IS) was theoretically calculated to guide their chemical synthesis. Second, the lack of an isotope effect on drug exposure was evaluated in a monkey study by i.v. dosing a mixture of the SIL and the unlabeled drugs. Third, after the SIL drug (100 μg) was concurrently i.v. dosed to humans, at T(max) of an oral therapeutic dose of the unlabeled drug, both drugs in plasma specimens were simultaneously quantified by a sensitive and accurate SRM assay. This strategy significantly improves bioanalytical data quality and saves time, costs, and resources by avoiding a traditional absolute bioavailability study or the newer approach of microdoses of a radio-microtracer measured by accelerator mass spectrometry.
Related Papers
- → Approaches using molecular imaging technology — use of PET in clinical microdose studies(2010)110 cited
- → Sensitivity-Based Analytical Approaches to Support Human Absolute Bioavailability Studies(2014)19 cited
- Pediatric Microdose Study of ( 14 C)Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept Miriam G. MooijEsther van DuijnCatherijne A. J. KnibbeAlbert D. Windhorst • N. Harry HendrikseWouter H. J. VaesEdwin SpaansBabs O. Fabriek • Hugo SandmanDimitri GrossouwLidwien M. HanffPaul J. J. M. Janssen • Birgit C. P. KochDick TibboelSaskia N. de Wildt(2014)
- → Study of Ultra‐Sensitive AMS Method to Identify Drug–Drug Interactions between Ciprofloxacin and Microdose 14C‐Caffeine(2018)